Edward J. Sitar, Chief Financial Officer at CANCER GENETICS, INC (CGIX), bought 500 shares at $6.26 ($3K) on 2014-12-12, disclosed to the SEC on 2014-12-15.
Open-market purchase of $3k CGIX by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| NMTR | BUY | 2021-04-06 | $50K | — | Filing → |
| NMTR | BUY | 2020-12-17 | $40K | — | Filing → |
| CGIX | SELL | 2016-11-16 | $5K | — | Filing → |